Why are we still waiting for a male contraceptive pill?
Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the University of Texas and Prof Chris Barratt from the University of Dundee to find out why male contraceptives have been so difficult to develop, and what kind of options are in the pipeline
February 8, 202416m 7s
Audio is streamed directly from the publisher (flex.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Despite research into a male contraceptive pill starting around the same time as its female counterpart, no product has ever made it to market. But that could soon change, with a new non-hormonal male pill entering human trials in the UK late last year. Ian Sample speaks to bioethicist Prof Lisa Campo-Engelstein of the University of Texas and Prof Chris Barratt from the University of Dundee about why male contraceptives have been so difficult to develop, and what kind of options are in the pipeline. Help support our independent journalism at <a href="https://www.theguardian.com/sciencepod">theguardian.com/sciencepod</a>
Topics
ScienceMedical researchContraception and family planningHealthMen's healthWomen's healthSocietyReproductionBiology